Utility of Epstein-Barr Virus Biomarkers in Human Immunodeficiency Virus-related Lymphomas in the Modern Combined Antiretroviral Therapy Era
- PMID: 30204857
- DOI: 10.1093/cid/ciy786
Utility of Epstein-Barr Virus Biomarkers in Human Immunodeficiency Virus-related Lymphomas in the Modern Combined Antiretroviral Therapy Era
Comment in
-
Reply to Lupo et al.Clin Infect Dis. 2019 Feb 15;68(5):892-893. doi: 10.1093/cid/ciy788. Clin Infect Dis. 2019. PMID: 30204856 No abstract available.
Comment on
-
Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus-related Lymphomas.Clin Infect Dis. 2019 Feb 15;68(5):834-843. doi: 10.1093/cid/ciy542. Clin Infect Dis. 2019. PMID: 29982484
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
